Utility and Feasibility of Simulation-based Training in Teaching Concepts of Traumatic Brain Management to Neurology Trainees (P8-2.001)

Abstract

<h3>Objective:</h3> To assess the feasibility and utility of simulation-based training in teaching concepts surrounding management of traumatic brain injury (TBI). <h3>Background:</h3> Neurology trainees respond to neurological emergencies but often do not have the opportunity to practice implementing their clinical knowledge and communication skills in managing such emergencies outside the clinical setting. <h3>Design/Methods:</h3> We developed a simulation-based training program for neurology residents to practice managing a patient presenting with acute TBI under the direct supervision of an expert in neurocritical care with opportunities for debriefing and feedback. The educational aims of the simulation were to familiarize learners with Brain Trauma Foundation guidelines on the management of TBI and to allow learners to practice closed loop communication in a multidisciplinary team. The simulation involved two learners, one confederate playing the role of emergency room nurse and ICU fellow, and a hired actor who played the role of the patient. Prior to the simulation, learners were given a 10-slide presentation to review relevant topics. A total of 40 minutes was allotted per session; 5 minutes to introduce the scenario, 20 minutes to complete the scenario, and 10 minutes for a debriefing. The effect of the simulation on learner aptitude in managing TBI was assessed via anonymous post-test. <h3>Results:</h3> A total of 8 learners participated in the simulation-based training. We were able to complete all simulation sessions in the allotted 40-minute time frame. On post-test reporting, 7/8 learners felt confident in managing TBI, 8/8 felt their confidence improved with the simulation, and 8/8 endorsed comfort in accessing resources regarding TBI guidelines. <h3>Conclusions:</h3> Teaching TBI management via simulation-based training is feasible and allows trainees to gain experience and comfort managing TBI. <b>Disclosure:</b> Dr. Franzova has nothing to disclose. Dr. Waldrop has nothing to disclose. Dr. Nwankwo has nothing to disclose. Dr. Ader has nothing to disclose. Dr. Bell has nothing to disclose. Dr. Velazquez has nothing to disclose. Dr. Agarwal has nothing to disclose. Dr. Roh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Portola Pharmaceuticals. Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health. Sander Connolly has received intellectual property interests from a discovery or technology relating to health care. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus. Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Amiel has nothing to disclose. Dr. Ghoshal has nothing to disclose.